ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Emphysema Drug Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-2M10229
Home | Market Reports | Health| Pharmacy
Global Emphysema Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Emphysema Drug Market Research Report 2025

Code: QYRE-Auto-2M10229
Report
January 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Angion Biomedica Corp
ProMetic Life Sciences Inc
REVO Biologics Inc
SATT North SAS
TGV-Laboratories

Emphysema Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Emphysema Drug Market

Emphysema Drug Market

The global market for Emphysema Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Emphysema Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Drug.
The Emphysema Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Emphysema Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Emphysema Drug Market Report

Report Metric Details
Report Name Emphysema Drug Market
CAGR 5%
Segment by Type
  • BB-3
  • EDO-66
  • MG-53
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS, TGV-Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Emphysema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Emphysema Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Emphysema Drug Market report?

Ans: The main players in the Emphysema Drug Market are Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS, TGV-Laboratories

What are the Application segmentation covered in the Emphysema Drug Market report?

Ans: The Applications covered in the Emphysema Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Emphysema Drug Market report?

Ans: The Types covered in the Emphysema Drug Market report are BB-3, EDO-66, MG-53, Others

Recommended Reports

Respiratory Disease Drugs

Sleep and Ventilatory Care

Cardiovascular and Critical Care

1 Emphysema Drug Market Overview
1.1 Product Definition
1.2 Emphysema Drug by Type
1.2.1 Global Emphysema Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 BB-3
1.2.3 EDO-66
1.2.4 MG-53
1.2.5 Others
1.3 Emphysema Drug by Application
1.3.1 Global Emphysema Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Emphysema Drug Market Size Estimates and Forecasts
1.4.1 Global Emphysema Drug Revenue 2020-2031
1.4.2 Global Emphysema Drug Sales 2020-2031
1.4.3 Global Emphysema Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Emphysema Drug Market Competition by Manufacturers
2.1 Global Emphysema Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Emphysema Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Emphysema Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Emphysema Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Emphysema Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Emphysema Drug, Product Type & Application
2.7 Global Key Manufacturers of Emphysema Drug, Date of Enter into This Industry
2.8 Global Emphysema Drug Market Competitive Situation and Trends
2.8.1 Global Emphysema Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Emphysema Drug Players Market Share by Revenue
2.8.3 Global Emphysema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Emphysema Drug Market Scenario by Region
3.1 Global Emphysema Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Emphysema Drug Sales by Region: 2020-2031
3.2.1 Global Emphysema Drug Sales by Region: 2020-2025
3.2.2 Global Emphysema Drug Sales by Region: 2026-2031
3.3 Global Emphysema Drug Revenue by Region: 2020-2031
3.3.1 Global Emphysema Drug Revenue by Region: 2020-2025
3.3.2 Global Emphysema Drug Revenue by Region: 2026-2031
3.4 North America Emphysema Drug Market Facts & Figures by Country
3.4.1 North America Emphysema Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Emphysema Drug Sales by Country (2020-2031)
3.4.3 North America Emphysema Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Emphysema Drug Market Facts & Figures by Country
3.5.1 Europe Emphysema Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Emphysema Drug Sales by Country (2020-2031)
3.5.3 Europe Emphysema Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Emphysema Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Emphysema Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Emphysema Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Emphysema Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Emphysema Drug Market Facts & Figures by Country
3.7.1 Latin America Emphysema Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Emphysema Drug Sales by Country (2020-2031)
3.7.3 Latin America Emphysema Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Emphysema Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Emphysema Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Emphysema Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Emphysema Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Emphysema Drug Sales by Type (2020-2031)
4.1.1 Global Emphysema Drug Sales by Type (2020-2025)
4.1.2 Global Emphysema Drug Sales by Type (2026-2031)
4.1.3 Global Emphysema Drug Sales Market Share by Type (2020-2031)
4.2 Global Emphysema Drug Revenue by Type (2020-2031)
4.2.1 Global Emphysema Drug Revenue by Type (2020-2025)
4.2.2 Global Emphysema Drug Revenue by Type (2026-2031)
4.2.3 Global Emphysema Drug Revenue Market Share by Type (2020-2031)
4.3 Global Emphysema Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Emphysema Drug Sales by Application (2020-2031)
5.1.1 Global Emphysema Drug Sales by Application (2020-2025)
5.1.2 Global Emphysema Drug Sales by Application (2026-2031)
5.1.3 Global Emphysema Drug Sales Market Share by Application (2020-2031)
5.2 Global Emphysema Drug Revenue by Application (2020-2031)
5.2.1 Global Emphysema Drug Revenue by Application (2020-2025)
5.2.2 Global Emphysema Drug Revenue by Application (2026-2031)
5.2.3 Global Emphysema Drug Revenue Market Share by Application (2020-2031)
5.3 Global Emphysema Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Angion Biomedica Corp.
6.1.1 Angion Biomedica Corp. Company Information
6.1.2 Angion Biomedica Corp. Description and Business Overview
6.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Angion Biomedica Corp. Emphysema Drug Product Portfolio
6.1.5 Angion Biomedica Corp. Recent Developments/Updates
6.2 ProMetic Life Sciences Inc.
6.2.1 ProMetic Life Sciences Inc. Company Information
6.2.2 ProMetic Life Sciences Inc. Description and Business Overview
6.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio
6.2.5 ProMetic Life Sciences Inc. Recent Developments/Updates
6.3 rEVO Biologics, Inc.
6.3.1 rEVO Biologics, Inc. Company Information
6.3.2 rEVO Biologics, Inc. Description and Business Overview
6.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 rEVO Biologics, Inc. Emphysema Drug Product Portfolio
6.3.5 rEVO Biologics, Inc. Recent Developments/Updates
6.4 SATT North SAS
6.4.1 SATT North SAS Company Information
6.4.2 SATT North SAS Description and Business Overview
6.4.3 SATT North SAS Emphysema Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SATT North SAS Emphysema Drug Product Portfolio
6.4.5 SATT North SAS Recent Developments/Updates
6.5 TGV-Laboratories
6.5.1 TGV-Laboratories Company Information
6.5.2 TGV-Laboratories Description and Business Overview
6.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TGV-Laboratories Emphysema Drug Product Portfolio
6.5.5 TGV-Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Emphysema Drug Industry Chain Analysis
7.2 Emphysema Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Emphysema Drug Production Mode & Process Analysis
7.4 Emphysema Drug Sales and Marketing
7.4.1 Emphysema Drug Sales Channels
7.4.2 Emphysema Drug Distributors
7.5 Emphysema Drug Customer Analysis
8 Emphysema Drug Market Dynamics
8.1 Emphysema Drug Industry Trends
8.2 Emphysema Drug Market Drivers
8.3 Emphysema Drug Market Challenges
8.4 Emphysema Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Angion Biomedica Corp
ProMetic Life Sciences Inc
REVO Biologics Inc
SATT North SAS
TGV-Laboratories
List of Tables
 Table 1. Global Emphysema Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Emphysema Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Emphysema Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Emphysema Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Emphysema Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Emphysema Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Emphysema Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Emphysema Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Emphysema Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Emphysema Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Emphysema Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Emphysema Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Emphysema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Emphysema Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Emphysema Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Emphysema Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Emphysema Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Emphysema Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Emphysema Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Emphysema Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Emphysema Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Emphysema Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Emphysema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Emphysema Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Emphysema Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Emphysema Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Emphysema Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Emphysema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Emphysema Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Emphysema Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Emphysema Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Emphysema Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Emphysema Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Emphysema Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Emphysema Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Emphysema Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Emphysema Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Emphysema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Emphysema Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Emphysema Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Emphysema Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Emphysema Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Emphysema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Emphysema Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Emphysema Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Emphysema Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Emphysema Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Emphysema Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Emphysema Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Emphysema Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Emphysema Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Emphysema Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Emphysema Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Emphysema Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Emphysema Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Emphysema Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Emphysema Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Emphysema Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Emphysema Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Emphysema Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Emphysema Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Emphysema Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Emphysema Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Emphysema Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Emphysema Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Emphysema Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Emphysema Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Angion Biomedica Corp. Company Information
 Table 71. Angion Biomedica Corp. Description and Business Overview
 Table 72. Angion Biomedica Corp. Emphysema Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Angion Biomedica Corp. Emphysema Drug Product
 Table 74. Angion Biomedica Corp. Recent Developments/Updates
 Table 75. ProMetic Life Sciences Inc. Company Information
 Table 76. ProMetic Life Sciences Inc. Description and Business Overview
 Table 77. ProMetic Life Sciences Inc. Emphysema Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. ProMetic Life Sciences Inc. Emphysema Drug Product
 Table 79. ProMetic Life Sciences Inc. Recent Developments/Updates
 Table 80. rEVO Biologics, Inc. Company Information
 Table 81. rEVO Biologics, Inc. Description and Business Overview
 Table 82. rEVO Biologics, Inc. Emphysema Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. rEVO Biologics, Inc. Emphysema Drug Product
 Table 84. rEVO Biologics, Inc. Recent Developments/Updates
 Table 85. SATT North SAS Company Information
 Table 86. SATT North SAS Description and Business Overview
 Table 87. SATT North SAS Emphysema Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. SATT North SAS Emphysema Drug Product
 Table 89. SATT North SAS Recent Developments/Updates
 Table 90. TGV-Laboratories Company Information
 Table 91. TGV-Laboratories Description and Business Overview
 Table 92. TGV-Laboratories Emphysema Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. TGV-Laboratories Emphysema Drug Product
 Table 94. TGV-Laboratories Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Emphysema Drug Distributors List
 Table 98. Emphysema Drug Customers List
 Table 99. Emphysema Drug Market Trends
 Table 100. Emphysema Drug Market Drivers
 Table 101. Emphysema Drug Market Challenges
 Table 102. Emphysema Drug Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Emphysema Drug
 Figure 2. Global Emphysema Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Emphysema Drug Market Share by Type: 2024 & 2031
 Figure 4. BB-3 Product Picture
 Figure 5. EDO-66 Product Picture
 Figure 6. MG-53 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Emphysema Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Emphysema Drug Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Emphysema Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Emphysema Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Emphysema Drug Sales (2020-2031) & (K Pcs)
 Figure 16. Global Emphysema Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Emphysema Drug Report Years Considered
 Figure 18. Emphysema Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Emphysema Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Emphysema Drug Players: Market Share by Revenue in Emphysema Drug in 2024
 Figure 21. Emphysema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Emphysema Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Emphysema Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Emphysema Drug Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Emphysema Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Emphysema Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Emphysema Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Emphysema Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Emphysema Drug Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Emphysema Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Emphysema Drug Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Emphysema Drug Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Emphysema Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Emphysema Drug by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Emphysema Drug by Type (2020-2031)
 Figure 58. Global Emphysema Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Emphysema Drug by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Emphysema Drug by Application (2020-2031)
 Figure 61. Global Emphysema Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Emphysema Drug Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Research Report 2025
Global Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report 2024
Global Chronic Obstructive Pulmonary Disease Clinical Therapeutics Market Research Report 2025
Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pulmonary Embolism Drug Market Research Report 2025
Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhaled Anti Infectives Market Research Report 2025
Global Aerosol Bronchodilator Market Research Report 2025
Asthma and COPD Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Proton Pump Inhibitor Drug Market Research Report 2025
Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalation Preparation Market Research Report 2025
Global Pulmonary Hypertension Drug Market Research Report 2025
Global Pharmaceutical Aerosol Market Research Report 2024
Global Sleep Apnea Therapy System Market Research Report 2025
Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions